Cargando…

Circulating Inflammatory Cytokine Associated with Poor Prognosis in Moyamoya Disease: A Prospective Cohort Study

Inflammation is a key factor in the development of moyamoya disease. However, the cytokine distribution in moyamoya disease and its impact on prognosis remain unclear. A total of 204 patients with moyamoya disease were enrolled in this study. The peripheral blood was analyzed for baseline data and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wei, Sun, Jian, Shi, Zhiyong, Huang, Zheng, Yu, Lebao, Du, Haibin, Ge, Peicong, Zhang, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917516/ https://www.ncbi.nlm.nih.gov/pubmed/36769472 http://dx.doi.org/10.3390/jcm12030823

Ejemplares similares

Predictors of preoperative cognitive dysfunction in adults with Moyamoya disease: a preliminary research
por: Sun, Jian, et al.
Publicado: (2022)

Circulating choline pathway nutrients and risk of moyamoya disease
por: Ge, Peicong, et al.
Publicado: (2022)

Hyperhomocysteinemia Is a Predictor for Poor Postoperative Angiogenesis in Adult Patients With Moyamoya Disease
por: He, Qiheng, et al.
Publicado: (2022)

Association Between Ultrasound Parameters and History of Ischemic or Hemorrhagic Stroke in Patients With Moyamoya Disease
por: Zheng, Shuai, et al.
Publicado: (2021)

Association of circulating branched-chain amino acids with risk of moyamoya disease
por: Zeng, Chaofan, et al.
Publicado: (2022)

Risk factors for postoperative ischemic complications in pediatric moyamoya disease
por: Deng, Xiaofeng, et al.
Publicado: (2021)

Clinical Significance of Ultrasound-Based Hemodynamic Assessment of Extracranial Internal Carotid Artery and Posterior Cerebral Artery in Symptomatic and Angiographic Evolution of Moyamoya Disease: A Preliminary Study
por: Zheng, Shuai, et al.
Publicado: (2021)

Association of Brain-Gut Peptides with Inflammatory Cytokines in Moyamoya Disease
por: Han, Wenxiu, et al.
Publicado: (2020)

Clinical and Radiological Outcomes After Revascularization of Hemorrhagic Moyamoya Disease
por: Kang, Kaijiang, et al.
Publicado: (2020)

Association between systemic immune-inflammatory markers and the risk of moyamoya disease: a case-control study
por: Liu, Wei, et al.
Publicado: (2023)

Angiographic Outcomes of Direct and Combined Bypass Surgery in Moyamoya Disease
por: Ge, Peicong, et al.
Publicado: (2019)

Gut microbiota in adults with moyamoya disease: characteristics and biomarker identification
por: Yu, Xiaofan, et al.
Publicado: (2023)

Plasma urea cycle metabolite levels and the risk of moyamoya disease
por: Yu, Xiaofan, et al.
Publicado: (2023)

Postoperative collateral formation after indirect bypass for hemorrhagic moyamoya disease
por: Ge, Peicong, et al.
Publicado: (2020)

Association between methionine sulfoxide and risk of moyamoya disease
por: Li, Junsheng, et al.
Publicado: (2023)

Difference in Cerebral Circulation Time between Subtypes of Moyamoya Disease and Moyamoya Syndrome
por: Kang, Kaijiang, et al.
Publicado: (2017)

Pathological Circulating Factors in Moyamoya Disease
por: Fang, Yao-Ching, et al.
Publicado: (2021)

Serum Kynurenic Acid and Kynurenine Are Negatively Associated with the Risk of Adult Moyamoya Disease
por: Yu, Xiaofan, et al.
Publicado: (2022)

Hypo-high density lipoproteinemia is a predictor for recurrent stroke during the long-term follow-up after revascularization in adult moyamoya disease
por: Yu, Xiaofan, et al.
Publicado: (2022)

Integrated analysis of the association between methionine cycle and risk of moyamoya disease
por: Li, Junsheng, et al.
Publicado: (2023)

Direct Bypass Surgery Vs. Combined Bypass Surgery for Hemorrhagic Moyamoya Disease: A Comparison of Angiographic Outcomes
por: Zhao, Yahui, et al.
Publicado: (2018)

Different subtypes of collateral vessels in hemorrhagic moyamoya disease with p.R4810K variant
por: Ge, Peicong, et al.
Publicado: (2020)

Digital subtraction angiographic characteristics of progression of moyamoya disease 6 months prior to surgical revascularisation
por: Ge, Peicong, et al.
Publicado: (2020)

Correlation of Serum N-Acetylneuraminic Acid with the Risk of Moyamoya Disease
por: Liu, Chenglong, et al.
Publicado: (2023)

Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease
por: MIKAMI, Takeshi, et al.
Publicado: (2019)

Association Between p.R4810K Variant and Long-Term Clinical Outcome in Patients With Moyamoya Disease
por: Ge, Peicong, et al.
Publicado: (2019)

Circulating Vascular Progenitor Cells in Moyamoya Disease
por: Kang, Hyun-Seung, et al.
Publicado: (2015)

Moyamoya disease involving anterior and posterior circulation
por: Verma, Rajesh, et al.
Publicado: (2016)

APOE as potential biomarkers of moyamoya disease
por: Wu, Haibin, et al.
Publicado: (2023)

Risk factors of postoperative cerebral hyperperfusion syndrome and its relationship with clinical prognosis in adult patients with moyamoya disease
por: Shi, Zhiyong, et al.
Publicado: (2023)

Prospective Screening of Family Members with Moyamoya Disease Patients
por: Han, Cong, et al.
Publicado: (2014)

Circulating endothelial progenitor cells and endothelial cells in moyamoya disease
por: Bao, Xiang‐Yang, et al.
Publicado: (2018)

Haemodynamic analysis of adult patients with moyamoya disease: CT perfusion and DSA gradings
por: Shi, Zhiyong, et al.
Publicado: (2020)

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
por: Chen, Yibing, et al.
Publicado: (2018)

Moyamoya Syndrome: A Window of Moyamoya Disease
por: Phi, Ji Hoon, et al.
Publicado: (2015)

Different aspects of cognitive function in adult patients with moyamoya disease and its clinical subtypes
por: Shi, Zhiyong, et al.
Publicado: (2020)

Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease
por: HE, JIN, et al.
Publicado: (2014)

Proposal for a Prospective Registry for Moyamoya Disease in Japan
por: KAZUMATA, Ken, et al.
Publicado: (2017)

What and why: the current situation and future prospects of “ivy sign” in moyamoya disease
por: Yu, Jin, et al.
Publicado: (2020)

Imaging of Moyamoya Disease and Moyamoya Syndrome: Current Status
por: Li, Jincheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1etb6nme91lnqh81591u7r4gna